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• Perfusion Overview and Workflow




• Mass transfer performance
• Cell culture case study




• Feed addition from D3-end
• Volume change in reactor
• High titers achievable
• Large production vessels 
(≥2000L)
Perfusion vs. Fed-batch
• Continuous filtration for ≥21 days
• Cell retention usually via filtration (0.2-
0.65µm)
• Concentrated Fed-batch uses 30-50 kDa
• Used for:
• Unstable products



















• Healthier culture with less waste = predictable 
product quality
• Higher cell densities
• Consistency from steady state production
• Less frequent bioreactor turnaround
• Clean harvest stream for DSP





• What is steady state?
• Process control and integration
• More complex setup (Regulatory)
• High validation costs
• Filter fouling leads to culture shutdown




• Thermo Fisher Scientific Offerings:
• Cell line development
• Media optimization
• Media hydration
• Sterile media hold




• Bulk storage and final fill
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• Custom 500 L S.U.B. configuration
• Standard impeller (25.1 cm diameter)
• Standard laser DHS (980 pores, 0.368 mm Ø)
• 2 ea frit (1 standard, 1 additional)
• Standard Dynamic kLa testing
• 1 g/L pluronic
• 3.5 g/L HEPES
• DHS = 15 slpm
• Agitation = 150 RPM (65 W/m3)
• Limited benefit from running frits at extreme flow rates even at max RPM
• Combined air sparge of 95 slpm (0.19 VVM) = ~42/hr
• Second option would be to increase DHS sparging rate















10 36.5 37.6 38.1
20 37.6 40.5 42.6
40 39.6 40.2 41.9
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• Implement upsized impeller (1000 L impeller in 500 L S.U.B., etc.)
S.U.B. Mixing Enhancements
S.U.B. Size 50 100 250 500












r Diameter (cm) 11.11 14.6 20 25.1
Speed at 20 W/m3 (RPM) 182.5 145.8 117.1 101.1











r Diameter (cm) 14.6 20 25.1 32.1
Speed at 20 W/m3 (RPM)
115.7 86.3 80.2 67.1
Max PIV at max RPM (W/m3)
103.2 248.9 130.8 223.7
Maximum power input 
limited in Legacy Systems
Expanded power input 
in Enhanced Systems
All systems meet objective of 100 W/m3
Note: Safely within the qualified design space of the 1000L/2000L S.U.M. (rated up to 350 RPM).
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1. Enhanced DHS for each S.U.B. size
• Increased DHS efficiency (smaller 
pore/bubble)
• Boost capacity (0.2 VVM @ <15m/s GEV)
• Frit optional in all S.U.B. designs
2. Upsized impeller in each S.U.B. size 
(n+1)
3. SU foam sensor for automated antifoam 
dispensing
4. Port for cell bleed – maintain cell density 
in perfusion cultures
5. 1” ID ATF/TFF connections available
S.U.B. BPC Perfusion Enhancements
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Characterization Results with Enhanced Sparging and Mixing
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Seed Density 0.4 x 106 cells/mL
Target Cell Density Various up to maximum
Media Composition
CD OptiCHO media
+ 100 ng/mL LR3




(10,000 ppm simethicone stock)








Bioreactor W.V. 40 L
Temp 37oC
DO Setpoint 30% (O2/air through DHS)
pH 7.0 ± 0.2 (CO2)




Antifoam dosing Sensor-based antifoam addition
Glucose Feed Maintain 1-3 g/L with constant feed







0.2 micron PES HF
Filter SA 2.53 m2
Perfusion rate
Day 0-3: None
Day 3-26: variable depending on 
cell density/nutrient demands, 1-4 
VVD (40-160 L/day)
Flux 0.67-2.67 LMH
ATF Rate 19.2 LPM
Shear Rate 2264 s-1
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• Standard
• DO (TruFluor DO)
• pH
• RTD
• Foam sensor linked to antifoam pump
• Cell density sensor linked to cell bleed pump














Cell density balance (probe-less)








































• VR = reactor working volume
• XR = cell density
• dXR/dt = cell density change over time
• μ = cell growth rate
• QB = reactor bleed rate
Equation
• Change in cell density = effective growth – cell bleed
• Rearrange, integrate, solve for QB to obtain bleed rate
• Best to average growth rates over multiple days
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qGµ XR GR VR
QP=VR · D










= 𝑉𝑅 ∙ 𝜇 ∙ 𝑋𝑅 − 𝑄𝐵 ∙ 𝑋𝑅
Overall Glucose Consumption: 
𝑑𝐺𝑅
𝑑𝑡















qG = gluc consumption
V = volume
X = [cells]
D = perfusion rate
14
Cell Culture Results – 50 L S.U.B. Cells
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Cell Culture Results – 50 L S.U.B. Culture Parameters
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Cell Culture Results – 50 L S.U.B. with Antifoam Control Loop
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Cell Culture Results – 50 L S.U.B. Gassing, Agitation
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• Can we build an equation to model sustainable cell concentration 
based on mixing and gassing?
• 𝑂𝑈𝑅 = 𝑞𝑂2 ∙ 𝐶𝑋
• 𝑂𝑇𝑅 = 𝑘𝐿𝑎 ∙ 𝐶𝑂2
∗ − 𝐶𝑂2





𝑘𝐿𝑎 = 𝛼 ∙ 𝑃𝐼𝑉
𝛽 ∙ 𝑣𝑣𝑚𝛾
• If 𝑂𝑈𝑅 = 𝑂𝑇𝑅




− 𝑝𝑝𝑂2,𝑎𝑖𝑟 ∙ 𝑆𝑃
Mass Balance Models – Cells = f(gassing, mixing)
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• pH = baseline pH – acid buildup + base buildup
• Acid/base accumulations




• 𝑘𝐿𝑎𝐶𝑂2 = 𝛼 ∙ 𝑃𝐼𝑉
𝛽 ∙ 𝑣𝑣𝑚𝛾
• ∴ 𝐶𝑂2 =
𝑝𝐻
𝑘𝐿𝑎𝐶𝑂2∙ 𝑎𝑐𝑖𝑑 𝑏𝑢𝑖𝑙𝑑𝑢𝑝 ∙ 𝑏𝑎𝑠𝑒 𝑏𝑢𝑖𝑙𝑑𝑢𝑝
Mass Balance Models – CO2 = f(acids, base)
20
• S.U.B. enhancements lead to 3-4 fold increases in oxygen mass transfer from legacy vessels 
• Scalability of S.U.B.s
• High degree of automation vital to perfusion success
• Achieved >260 x 106 cells/mL in cell culture
• Room for more oxygen mass transfer at all scales
• Highly automated process controlling DO, pH, dCO2
• Predictive mass transfer models based on culture data
• Further work to be done optimizing media and exchange rates
Conclusions
